Estrogen-mediated down-regulation of E-cadherin in breast cancer cells

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5203-5208

  Oesterreich, Steffi ^a   Deng, Wanleng ^a   Jiang, Shiming ^a   Cui, Xiaojiang ^a   Ivanova, Margarita ^a   Schiff, Rachel ^a   Kang, Kaiyan ^a   Hadsell, Darryl L ^a   Behrens, Jürgen ^b   Lee, Adrian V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; UVOMORULIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL INTERACTION; CHROMATIN; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

BREAST NEOPLASMS; CADHERINS; CELL LINE, TRANSFORMED; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0141705467     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Berx, G., and Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res., 3: 289-293, 2001.
2. Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., and Hart, I. R. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer, 92: 404-408, 2001.
3. Nass, S. J., Herman, J. G., Gabrielson, E., Iversen, P. W., Parl, F. F., Davidson, N. E., and Graff, J. R. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res., 60: 4346-4348, 2000.
4. Hajra, K. M., Ji, X., and Fearon, E. R. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene, 18: 7274-7279, 1999.
5. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E., Behrens, J., Sommer, T., and Birchmeier, W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol., 4: 222-231, 2002.
6. Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., and Garcia De Herreros, A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2: 84-89, 2000.
7. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2: 76-83, 2000.
8. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7: 1267-1278, 2001.
9. Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., and Wade, P. A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell, 113: 207-219, 2003.
10. Oesterreich, S., Zhang, Q., Hopp, T., Fuqua, S. A., Michaelis, M., Zhao, H. H., Davie, J. R., Osborne, C. K., and Lee, A. V. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol. Endocrinol., 14: 369-381, 2000.
11. Behrens, J., Lowrick, O., Klein-Hitpass, L., and Birchmeier, W. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA, 88: 11495-11499, 1991.
12. Oesterreich, S., Lee, A. V., Sullivan, T. M., Samuel, S. K., Davie, J. R., and Fuqua, S. A. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J. Cell Biochem., 67: 275-286, 1997.
13. Townson, S., Dobrzycka, K. M., Lee, A. V., Air, M., Deng, W., Kang, K., Jiang, S., Noriyuki, K., Michaelis, K., and Oesterreich, S. SAFB2-a new SAFB homolog and estrogen receptor corepressor. J. Biol. Chem., 26: 26, 2003.
14. Hennig, G., Lowrick, O., Birchmeier, W., and Behrens, J. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem., 271: 595-602, 1996.
15. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103: 843-852, 2000.
16. Osborne, C. K., Coronado, E., Allred, D. C., Wiebe, V., and DeGregorio, M. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J. Natl. Cancer Inst. (Bethesda), 83: 1477-1482, 1991.
17. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., and O'Malley, B. W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA, 96: 1858-1862, 1999.
18. Prinsac, G. S., Birch, L., Habermann, H., Chang, W. Y., Tebeau, C., Putz, O., and Bieberich, C. Influence of neonatal estrogens on rat prostate development. Reprod. Fertil. Dev., 13: 241-252, 2001.
19. Habermann, H., Chang, W. Y., Birch, L., Mehta, P., and Prins, G. S. Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology, 142: 359-369, 2001.
20. MacCalman, C. D., Farookhi, R., and Blaschuk, O. W. Estradiol regulates N-cadherin mRNA levels in the mouse ovary. Dev. Genet., 16: 20-24, 1995.
21. MacCalman, C. D., Farookhi, R., and Blaschuk, O. W. Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary. Clin. Exp. Metastasis, 12: 276-282, 1994.
22. DePasquale, J. A. Rearrangement of the F-actin cytoskeleton in estradiol-treated MCF-7 breast carcinoma cells. Histochem. Cell Biol., 112: 341-350, 1999.
23. Kester, H. A., van der Leede, B. M., van der Saag, P. T., and van der Burg, B. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J. Biol. Chem., 272: 16637-16643, 1997.
24. Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C., Mareel, M. M., and Castronovo, V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res., 54: 4607-4609, 1994.
25. Charpentier, A. H., Bednarek, A. K., Daniel, R. L., Hawkins, K. A., Laflin, K. J., Gaddis, S., MacLeod, M. C., and Aldaz, C. M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res., 60: 5977-5983, 2000.
26. Lauritsen, K. J., List, H. J., Reiter, R., Wellstein, A., and Riegel, A. T. A role for TGF-β in estrogen and retinoid mediated regulation of the nuclear receptor coactivator A1B1 in MCF-7 breast cancer cells. Oncogene, 21: 7147-7155, 2002.
27. Katzenellenbogen, B. S., and Katzenellenbogen, J. A. Estrogen receptor transcription and transactivation: estrogen receptor α and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res., 2: 335-344, 2000.
28. Siitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., and Isola, J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol., 105: 394-402, 1996.
29. Lipponen, P., Saarelainen, E., Ji, H., Aaltomaa, S., and Syrjanen, K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol., 174: 101-109, 1994.
30. Pedersen, K. B., Nesland, J. M., Fodstad, O., and Maelandsmo, G. M. Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies. Br. J. Cancer, 87: 1281-1286, 2002.